Vol. 30 No. 4 (2017): Current Issues of Pharmacy and Medical Sciences

View Vol. 30 No. 4 (2017): Current Issues of Pharmacy and Medical Sciences
Published: 2025-04-25

Articles

  • Advances in surgery for peritoneal surface malignancies

    Jerzy Mielko, Karol Rawicz-Pruszynski, Tomasz Jastrzebski, Wojciech Polkowski (Author)
    171 - 172
    DOI: https://doi.org/10.1515/cipms-2017-0031

  • Treatment of peritoneal metastases from gastric carcinoma

    Wojciech Polkowski, Karol Rawicz-Pruszynski, Jerzy Mielko, Katarzyna Geca, Magdalena Skorzewska, Bogumila Cisel (Author)
    173 - 179
    DOI: https://doi.org/10.1515/cipms-2017-0032

  • Systemic treatment of Krukenberg tumors

    Agnieszka Kolak, Michal Lozinski, Slawomir Mandziuk (Author)
    180 - 183
    DOI: https://doi.org/10.1515/cipms-2017-0033

  • Risk of peritoneal dissemination in stomach cancer

    Robert Sitarz, Wojciech Polkowski, Ryszard Maciejewski, G Johan A Offerhaus (Author)
    184 - 186
    DOI: https://doi.org/10.1515/cipms-2017-0034

  • Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?

    Beate Rau, Eva Pachmayr, Dusan Klos, Peter Thuss-Patience, Andreas Brandl (Author)
    187 - 189
    DOI: https://doi.org/10.1515/cipms-2017-0035

  • Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments

    Roman Yarema (Author)
    190 - 194
    DOI: https://doi.org/10.1515/cipms-2017-0036

  • Surgical treatment of gastric carcinoma with ovarian metastases

    Tomasz Olesinski (Author)
    195 - 197
    DOI: https://doi.org/10.1515/cipms-2017-0037

  • Microbiological monitoring in patients with advanced ovarian cancer before and after cytoreductive surgery – a preliminary report

    Maria Szymankiewicz, Krzysztof Koper, Konrad Dziobek, Zbigniew Kojs, Lukasz Wicherek (Author)
    198 - 202
    DOI: https://doi.org/10.1515/cipms-2017-0038

  • Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?

    Malgorzata Skierucha, Karol Polom, Karol Rawicz-Pruszynski, Jerzy Mielko, Robert Sitarz, Ryszard Maciejewski, Franco Roviello, Wojciech Polkowski (Author)
    203 - 206
    DOI: https://doi.org/10.1515/cipms-2017-0039

  • Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

    Sebastian Blaj, Pompiliu Piso (Author)
    207 - 210
    DOI: https://doi.org/10.1515/cipms-2017-0040